Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Perl, S; Stiegler, P; Rotman, B; Prenner, G; Lercher, P; Anelli-Monti, M; Sereinigg, M; Riegelnik, V; Kvas, E; Kos, C; Heinzel, FR; Tscheliessnigg, KH; Pieske, B.
Socio-economic effects and cost saving potential of remote patient monitoring (SAVE-HM trial).
Int J Cardiol. 2013; 169(6):402-407
Doi: 10.1016/j.ijcard.2013.10.019
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Perl Sabine
- Co-Autor*innen der Med Uni Graz
- Anelli-Monti Michael
- Heinzel Frank
- Kos Cornelia
- Lercher Peter
- Pieske Burkert Mathias
- Prenner Günther
- Riegelnik Vesna
- Rotman Brigitte
- Sereinigg Michael
- Stiegler Philipp
- Tscheliessnigg Karlheinz
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- In the SAVE-trial we evaluated the safety, reliability and improvements of patient management using the BIOTRONIK Home Monitoring®-System (HM) in pacemaker (PM) and implanted cardioverter defibrillator (ICD) patients. 115 PM (Module A) and 36 ICD-patients (Module B) were recruited 3 months after implantation. 65 patients in Module A were randomised to HM-OFF and had one scheduled outpatient clinic follow-up(FU) per year, whereas patients randomised to HM-ON were equipped with the mobile transmitter and discharged without any further scheduled in-office FU. In Module B 18 patients were randomised to HM-OFF and followed by standard outpatient clinic controls every 6 months; 18 patients were randomised to HM-ON receiving remote monitoring plus one outpatient clinic visit per year; unscheduled follow-ups were performed when necessary. The average follow-up period was 17.1 ± 9.2 months in Module A and 26.3 ± 8.6 months in Module B. In both modules, the number of FUs per year was significantly reduced (Module A HM-ON 0.29 ± 0.6 FUs/year vs HM-OFF 0.53 ± 0.5 FUs/year; p b 0.001; Module B HM-ON 0.87 ± 0.25 vs HM-OFF 1.73 ± 0.53 FU/year,p b 0.001). Cost analysis was significantly lower in the HM-ON group compared to the HM-OFF group (18.0 ± 41.3 and 22.4 ± 26.9 € respectively; p b 0.003). 93% of the unscheduled visits in Module B were clinically indicated,whereas 55% of the routine FUs were classified as clinically unnecessary. Remote home monitoring of pacemaker and ICD devices was safe, reduced overall hospital visits, and detected events that mandated unscheduled visits.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Aged, 80 and over -
- Cost Savings - economics
- Defibrillators, Implantable - economics
- Female -
- Follow-Up Studies -
- Humans -
- Male -
- Middle Aged -
- Monitoring, Physiologic - economics
- Pacemaker, Artificial - economics
- Socioeconomic Factors -
- Telemedicine - economics
- Find related publications in this database (Keywords)
- SAVE
- Pacemaker
- ICD
- Remote monitoring